Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly variable. Established risk factors include the Mantle Cell Lymphoma International Prognostic Index (MIPI) and the quantification of the proliferation rate of the tumour cells, e.g. by Ki-67 immunohistoch...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Haematol
Autori principali: Rauert-Wunderlich, Hilka, Mottok, Anja, Scott, David W., Rimsza, Lisa M., Ott, German, Klapper, Wolfram, Unterhalt, Michael, Kluin-Nelemans, Hanneke C., Hermine, Olivier, Hartmann, Sylvia, Thorns, Christoph, Rymkiewicz, Grzegorz, Holte, Harald, Dreyling, Martin, Hoster, Eva, Rosenwald, Andreas
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6361690/
https://ncbi.nlm.nih.gov/pubmed/30095158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15519
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi